Community Academic Profiles–

Robert Harrington

Back to Profile

Publication Details

  • Intravenous platelet blockade with cangrelor during PCI.

    Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA. N Engl J Med. 2009; 361 (24): 2330-41

    Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI).

    PubMedID: 19915222

Stanford Medicine Resources:

Footer Links: